@article{a68bc3d904fd4ddcaf03cf8ca4bc6bd0,
title = "The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19",
abstract = "An ordinal tool is proposed to measure the full spectrum of functional outcomes following COVID-19. This “Post-COVID-19 Functional Status (PCFS) scale” can be used for tracking functional status over time as well as for research purposes. https://bit.ly/3cofGaa",
keywords = "IMPACT",
author = "Klok, \{Frederikus A.\} and Boon, \{Gudula J. A. M.\} and Stefano Barco and Matthias Endres and Geelhoed, \{J. J. Miranda\} and Samuel Knauss and Rezek, \{Spencer A.\} and Spruit, \{Martijn A.\} and Jorg Vehreschild and Bob Siegerink",
note = "Funding Information: Conflict of interest: F.A. Klok reports grants from Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, MSD, Actelion, the Netherlands Thrombosis Foundation and the Dutch Heart Foundation, outside the submitted work. G.J.A.M. Boon has nothing to disclose. S. Barco has nothing to disclose. M. Endres reports grants from DFG under Germany{\textquoteright}s Excellence Strategy (EXC-2049; 390688087) and Bayer, and personal fees from Bayer, Boehringer Ingelheim, BMS, Daiichi Sankyo, Amgen, GSK, Sanofi, Covidien, Novartis and Pfizer, outside the submitted work. J.J.M. Geelhoed has nothing to disclose. S. Knauss has nothing to disclose. S.A. Rezek has nothing to disclose. M.A. Spruit reports grants from the Netherlands Lung Foundation and Stichting Astma Bestrijding, and grants and personal fees from AstraZeneca and Boehringer Ingelheim, outside the submitted work. J. Vehreschild has nothing to disclose. B. Siegerink has nothing to disclose.",
year = "2020",
month = jul,
day = "1",
doi = "10.1183/13993003.01494-2020",
language = "English",
volume = "56",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",
}